Kristian Kofoed

Summary

Affiliation: Copenhagen University Hospital
Country: Denmark

Publications

  1. ncbi request reprint [Documented effect of extra corporeal photopheresis on T-cell mediated diseases]
    Kristian Kofoed
    Dermato venerologisk Afdeling D41, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 København NV, Denmark
    Ugeskr Laeger 173:1869-74. 2011
  2. ncbi request reprint [Prevention of herpes zoster by vaccination]
    Kristian Kofoed
    Dermato venerologisk Afdeling D41, Bispebjerg Hospital, 2400 København NV, Denmark
    Ugeskr Laeger 173:110-4. 2011
  3. ncbi request reprint [Herpes zoster: clinical manifestation, diagnosis and treatment]
    Kristian Kofoed
    Dermato venerologisk Afdeling D41, Bispebjerg Hospital, 2400 København NV, Denmark
    Ugeskr Laeger 173:114-9. 2011
  4. pmc Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections
    Kristian Kofoed
    Clinical Research Unit, Copenhagen University Hospital, Hvidovre, Kettegaard Alle 30, DK 2650 Hvidovre, Denmark
    Crit Care 11:R38. 2007
  5. ncbi request reprint [Epstein-Barr virus-associated large B-cell lymphoma in a patient with colitis ulcerosa treated with azathioprine]
    Kristian Kofoed
    Hvidovre Hospital, Klinisk Forskningsenhed 136, Infektionsmedicinsk Afdeling, Hvidovre
    Ugeskr Laeger 170:1255. 2008

Collaborators

Detail Information

Publications5

  1. ncbi request reprint [Documented effect of extra corporeal photopheresis on T-cell mediated diseases]
    Kristian Kofoed
    Dermato venerologisk Afdeling D41, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 København NV, Denmark
    Ugeskr Laeger 173:1869-74. 2011
    ..Studies have documented an effect of ECP in GVHD and CTLC. ECP has been used to treat other T-cell mediated diseases, the documentation however is sparse. The side effects of ECP are few and not serious...
  2. ncbi request reprint [Prevention of herpes zoster by vaccination]
    Kristian Kofoed
    Dermato venerologisk Afdeling D41, Bispebjerg Hospital, 2400 København NV, Denmark
    Ugeskr Laeger 173:110-4. 2011
    ..The vaccine is approved for persons aged = 50 years. However, the clinical efficacy of the vaccine is best studied in people aged = 60 years. The vaccine has so far not shown any serious side-effects...
  3. ncbi request reprint [Herpes zoster: clinical manifestation, diagnosis and treatment]
    Kristian Kofoed
    Dermato venerologisk Afdeling D41, Bispebjerg Hospital, 2400 København NV, Denmark
    Ugeskr Laeger 173:114-9. 2011
    ....
  4. pmc Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections
    Kristian Kofoed
    Clinical Research Unit, Copenhagen University Hospital, Hvidovre, Kettegaard Alle 30, DK 2650 Hvidovre, Denmark
    Crit Care 11:R38. 2007
    ..Combinations of markers, as opposed to single ones, may improve diagnosis and thereby survival. We therefore compared the diagnostic characteristics of novel and routinely used biomarkers of sepsis alone and in combination...
  5. ncbi request reprint [Epstein-Barr virus-associated large B-cell lymphoma in a patient with colitis ulcerosa treated with azathioprine]
    Kristian Kofoed
    Hvidovre Hospital, Klinisk Forskningsenhed 136, Infektionsmedicinsk Afdeling, Hvidovre
    Ugeskr Laeger 170:1255. 2008
    ..AZA and 6-mercaptopurine are associated with the development of EBV-positive lymphomas in organ-transplanted patients. This type of lymphoma is a rare complication in inflammatory bowel disease...